癌症中的乳化:代谢-表观遗传联系和治疗边界
Chang Zhang1, Qingfei Meng2, Hui Jiao1
1Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun 130021, China.
Critical reviews in oncology/hematology
|November 21, 2025
概括
希斯乳化是一种新型蛋白质修饰,影响癌症代谢和基因表达. 本综述探讨了其在癌症中的双重作用,作为生物标志物的潜力,以及精确瘤学的治疗向.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 基斯乳酸化是一种新发现的翻译后修饰.
- 乳酸盐是糖解的产物,直接影响蛋白质的功能.
- 这种修饰在癌症代谢和进展中起着复杂的作用.
研究的目的:
- 审查当前对癌症中基因素乳化的理解.
- 探索乳糖化在瘤发生和瘤抑制中的双重作用.
- 讨论乳化的临床影响和治疗潜力.
主要方法:
- 文献综述综合了关于基因素乳基化的证据.
- 分析乳化在DNA修复,细胞循环和基因调节中的作用.
- 检查交叉与其他翻译后修改,如乙化和甲基化.
主要成果:
- 乳化可以促进或抑制瘤的进展,这取决于背景 (例如,MRE11-K673la与H3K18la).
- 被确定为新型乳化催化剂的阿兰-tRNA合成酶 (AARS1/2).
- 特定的乳化模式 (例如,H4K12la,p53-K120la) 显示出作为癌症生物标志物的潜力.
结论:
- 基斯乳化是一种关键的代谢传感器,在癌症中具有双重作用.
- 乳化与其他表观遗传修饰交叉,影响癌症表型.
- 向乳化提供了新的精确瘤学策略.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
